The Lancet Haematology

1. Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Bhavana Bhatnagar, Ann-Kathrin Eisfeld

2. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Heinz Ludwig, Pieter Sonneveld, Thierry Facon, Jesus San-Miguel, Hervé Avet-Loiseau, Mohamad Mohty, Maria-Victoria Mateos, Philippe Moreau, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Monika Engelhardt, Christoph Driessen, Gordon Cook, Melitios A Dimopoulos, Francesca Gay, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel

3. Harnessing the benefits of available targeted therapies in acute myeloid leukaemia

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Hagop Kantarjian, Nicholas J Short, Courtney DiNardo, Eytan M Stein, Naval Daver, Alexander E Perl, Eunice S Wang, Andrew Wei, Martin Tallman

4. Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Toby A Eyre, Anna Schuh, William G Wierda, Jennifer R Brown, Paolo Ghia, John M Pagel, Richard R Furman, Jean Cheung, Ahmed Hamdy, Raquel Izumi, Priti Patel, Min Hui Wang, Yan Xu, John C Byrd, Peter Hillmen

5. Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Kazunori Murai, Hiroshi Ureshino, Takashi Kumagai, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Nobuhiko Uoshima, Toru Kiguchi, Masayuki Mita, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda

6. Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Catherine Diefenbach, Brad S Kahl, Andrew McMillan, Javier Briones, Lalita Banerjee, Raul Cordoba, Fiona Miall, John M Burke, Jamie Hirata, Yanwen Jiang, Joseph N Paulson, Yi Meng Chang, Lisa Musick, Pau Abrisqueta

7. Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Jacob D Soumerai, Anthony R Mato, Ahmet Dogan, Venkatraman E Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim Hochberg, Jeffrey A Barnes, Audrey M Hamilton, Jeremy S Abramson, Connie L Batlevi, Matthew J Matasar, Ariela Noy, Colette N Owens, M Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma

8. Correction to Lancet Haematol 2021; 8: e828–39

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s):

9. Progressive multifocal leukoencephalopathy in the era of chimeric antigen receptor T-cell therapy

   Publication date: December 2021

   Source: The Lancet Haematology, Volume 8, Issue 12

   Author(s): Strachan Mackenzie, Arian Laurence, Maeve O’Reilly, Karl S Peggs, Claire Roddie

10. Acalabrutinib monotherapy in patients with Richter transformation

    Publication date: December 2021

    Source: The Lancet Haematology, Volume 8, Issue 12

    Author(s): Kirsten Fischer, Othman Al-Sawaf

11. Low-dose dasatinib: when less can be more

    Publication date: December 2021

    Source: The Lancet Haematology, Volume 8, Issue 12

    Author(s): Philip Crawford Amrein

12. Follicular lymphoma: is more better or is less really more?

    Publication date: December 2021

    Source: The Lancet Haematology, Volume 8, Issue 12

    Author(s): Kami Maddocks

13. A new triplet for chronic lymphocytic leukaemia: zanubrutinib–venetoclax–obinutuzumab

    Publication date: December 2021

    Source: The Lancet Haematology, Volume 8, Issue 12

    Author(s): Davide Rossi, Joyce Marques De Almeida

14. Removing unfair barriers to blood donation

    Publication date: December 2021

    Source: The Lancet Haematology, Volume 8, Issue 12

    Author(s): The Lancet Haematology

15. Vaccine-induced immune thrombotic thrombocytopenia

    Publication date: Available online 11 November 2021

    Source: The Lancet Haematology

    Author(s): Frederikus A Klok, Menaka Pai, Menno V Huisman, Michael Makris

16. Multi-organ graft-versus-host disease after nivolumab for relapsed Hodgkin lymphoma: the role of plasma exchange

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Rodothea Amerikanou, Lorna Neill, Manar Shafat, Harriet Roddy, Harpreet Hyare, Sian Hughes, Kirsty Thomson, Karl S Peggs, Arian Laurence, Maeve O'Reilly, Claire Roddie

17. Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Vanessa E Kennedy, Rebecca L Olin

18. A comprehensive approach to therapy of haematological malignancies in older patients

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Raul Cordoba, Toby A Eyre, Heidi D Klepin, Tanya M Wildes, Valentin Goede

19. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Amir Enshaei, Ajay Vora, Christine J Harrison, John Moppett, Anthony V Moorman

20. Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Sarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, Stefan K Barta, Nadia Khan, Robin Joyce, Kami Maddocks, Trisha Ali-Shaw, Silvia Senese, Ying Yuan, Jason Westin, John P Leonard

21. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Christiane Querfeld, John A Thompson, Matthew H Taylor, Jennifer A DeSimone, Jasmine M Zain, Andrei R Shustov, Carolyn Johns, Sue McCann, Gloria H Y Lin, Penka S Petrova, Robert A Uger, Naomi Molloy, Yaping Shou, Oleg E Akilov

22. Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Kevin R Kelly, Sikander Ailawadhi, David S Siegel, Leonard T Heffner, George Somlo, Sundar Jagannath, Todd M Zimmerman, Nikhil C Munshi, Sumit Madan, Asher Chanan-Khan, Sagar Lonial, Suraj Chandwani, Ashot Minasyan, Markus Ruehle, Farima Barmaki-Rad, Afsaneh Abdolzade-Bavil, Faiza Rharbaoui, Eva Herrmann-Keiner, Thomas Haeder, Andrea Wartenberg-Demand

23. Correction to Lancet Haematol 2021; 8: e711–22

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s):

24. Correction to Lancet Haematol 2021; 8: e67–79

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s):

25. Correction to Lancet Haematol 2021; 8: e55–66

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s):

26. Under-recognition of measurement and management of serum ferritin among populations at high risk of iron deficiency – Authors' reply

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Maria Elena Jefferds, Zuguo Mei, O Yaw Addo, Andrea J Sharma, Rafael C Flores-Ayala, Gary M Brittenham

27. Under-recognition of measurement and management of serum ferritin among populations at high risk of iron deficiency

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Tomohiko Sato, Rui Terada, Toshiyuki Ikeda

28. Living longer and better with haematological malignancies: a promise for older adults too?

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Martine Extermann

29. Redefining high hyperdiploid B-cell acute lymphoblastic leukaemia

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Marina Lafage-Pochitaloff

30. Dose-adjusted EPOCH-R plus venetoclax: a toxic bend in the road to improving R-CHOP?

    Publication date: November 2021

    Source: The Lancet Haematology, Volume 8, Issue 11

    Author(s): Martine E D Chamuleau